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Apoptosis, a form of programmed cell death, is exe-
cuted by a family of zymogenic proteases known as
caspases, which cleave an array of intracellular sub-
strates in the dying cell. Many proapoptotic stimuli
trigger cytochrome c release from mitochondria, pro-
moting the formation of a complex between Apaf-1
andcaspase-9 inacaspase-activatingstructure known
as the apoptosome. In this review, we describe knock-
out and knockin studies of apoptosome components,
elegant structural and biochemical experiments, and
analyses of the apoptosome in various cancers and
other disease states, all of which have provided new
insight into this critical locus of apoptotic control.
Introduction
Apoptosis, a form of programmed cell death, is a pro-
gram of cellular suicide critical for both proper embry-
onic development and homeostasis of adult tissues
(Danial and Korsmeyer, 2004). The apoptotic program
is executed by a family of highly conserved proteases
known as caspases, which dismantle the cell in an or-
derly fashion by cleaving a large number of cellular sub-
strates. Aberrant caspase regulation has been unequiv-
ocally linked to the pathogenesis of a variety of
diseases, including various neurological disorders and
cancers (Riedl and Shi, 2004).
Signaling pathways leading to caspase activation are
characterized as either extrinsic or intrinsic (summa-
rized in Figure 1). The extrinsic pathway involves the
binding of extracellular ligands (e.g., FasL) to cell sur-
face receptors (e.g., Fas), resulting in the recruitment
of cytosolic adaptor proteins (e.g., FADD), the activation
of initiator caspases (e.g., pro-caspase-8), and the sub-
sequent activation of downstream effector caspases
(Nagata, 1999). More germane to this review, proapo-
ptotic signals transmitted via the intrinsic pathway con-
verge on the mitochondria, resulting in outer membrane
permeablization and the subsequent release of cyto-
chrome c (a component of the electron transport chain)
and other proapoptotic molecules into the cytosol
(Green and Kroemer, 2004; Olson and Kornbluth,
2001). This process of mitochondrial cytochrome c re-
lease is intricately regulated by the Bcl-2 family of pro-
teins, which can both promote (e.g., Bax, Bak) or impede
(e.g., Bcl-2, Bcl-XL) cytochrome c release (Cory and
Adams, 2002). In the vast majority of cell types, cytosolic
cytochrome c is highly proapoptotic, stimulating cas-
pase activation by forming a large complex with a protein
called Apaf-1 and an initiator caspase, pro-caspase-9.
This structure, known as the apoptosome, then acti-
vates downstream effector caspases, eventually leading
*Correspondence: kornb001@mc.duke.eduto apoptosis (Liu et al., 1996; Srinivasula et al., 1998; Zou
et al., 1997).
Although particular apoptotic signals may stimulate
either the extrinsic or intrinsic pathway, crosstalk be-
tween these pathways occurs through an initiator cas-
pase engaged by the extrinsic pathway, caspase-8,
which can cleave and activate the proapoptotic Bcl-2
family member Bid to promote mitochondrial cyto-
chrome c release (Danial and Korsmeyer, 2004). The reg-
ulation of the intrinsic apoptotic program has been stud-
ied extensively, with the great majority of research
focused on regulation of Bcl-2 family members and mi-
tochondrial cytochrome c release. However, the discov-
ery of X-linked inhibitor of apoptosis (XIAP), which binds
to and directly inhibits the enzymatic activity of cas-
pases, demonstrated that apoptotic regulation can
also occur downstream of mitochondrial cytochrome c
release (Salvesen and Duckett, 2002). More recently,
many reports have established the apoptosome as a crit-
ical locus of apoptotic control, impinged upon by multi-
ple signaling pathways. We will discuss here the emerg-
ing importance of the apoptosome and its regulation
in physiological, developmental, and pathological
contexts.
Formation of the Apoptosome
The Vertebrate Apoptosome
Inhibiting apoptosome formation or function can halt
transmission of an apoptotic signal along the intrinsic
pathway. Conversely, enhancing the apoptosome can
boost the efficiency of apoptosis. In vertebrate cells,
apoptosome formation is initiated by the release of mito-
chondrial cytochrome c (summarized in Figure 2). The
cytochrome c binding partner, Apaf-1, exists in the cyto-
sol as an inactive monomer with three functional do-
mains: an N-terminal caspase recruitment domain
(CARD), a central region for nucleotide binding that is
homologous to CED-4 (discussed below), and a C-termi-
nal domain composed of multiple WD-40 repeats (Zou
et al., 1999). It is believed that cytosolic Apaf-1 lacking
bound cytochrome c exists in an inactive form, and
that the C-terminal domain acts as an autoinhibitor
through intramolecular contact with the N-terminal re-
gion of the protein. Once cytochrome c binds to the
C-terminal domain, it induces a conformational change
that permits its activation. In the presence of the nucle-
otide dATP, the Apaf-1/cytochrome c complex oligo-
merizes into a heptameric structure resembling a wheel
whose core contains seven N-terminal CARDs (Acehan
et al., 2002; Adrain et al., 1999; Srinivasula et al., 1998).
The formation of this complex allows interaction of
pro-caspase-9 with Apaf-1 through the interaction of
its own CARD with the CARD of Apaf-1, thus placing in-
dividual pro-caspase-9 molecules in close proximity
with one another and promoting their activation (Acehan
et al., 2002; Boatright et al., 2003; Yu et al., 2005). It has
recently been verified that this activation of caspase-9
on the apoptosome occurs via dimerization (Pop et al.,
2006). Interestingly, as determined by the crystal struc-
ture of the caspase-9 dimer, only one of the two subunits
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550Figure 1. Caspase Activation via the Intrinsic
and Extrinsic Pathways of Apoptosis
The activation of caspases during apoptosis
proceeds through two distinct mechanisms.
Activation of caspases through the extrinsic
pathway involves the binding of extracellular
ligands (e.g., FasL) to their cognate receptors
(e.g., Fas) and the recruitment of intracellular
adaptor proteins (e.g., FADD) to activate cas-
pase-8 and subsequent downstream effector
caspases. The intrinsic pathway involves the
release of cytochrome c from the mitochon-
dria into the cytosol. This leads to the forma-
tion of the apoptosome, the activation of cas-
pase-9, and the cleavage of effector
caspases.in the dimer is catalytically active (Boatright et al., 2003).
Active caspase-9 can then cleave and activate pro-cas-
pase-3 and pro-caspase-7 to execute the cell death pro-
gram (Li et al., 1997). Interestingly, the ability of caspase-
9 to efficiently activate caspase-3 has just been reported
to depend on an enhanced affinity of caspase-9 for cas-
pase-3 that only occurs after recruitment of caspase-9
to the apoptosome (Yin et al., 2006).
It should be noted that modification of cytochrome c
itself plays a role in apoptosome activation. Cytochrome
c is synthesized in its apo form (without a heme group)and is imported into the mitochondria, where heme ly-
ase can catalyze the addition of heme to produce
holo-cytochrome c (which is released from the mito-
chondria during apoptosis). Although apo-cytochrome
c is competent to bind Apaf-1, it fails to induce caspase
activation and Apaf-1 oligomerization (Martin and
Fearnhead, 2002; Martin et al., 2004). Interestingly, cyto-
chrome c has been shown to be nitrosylated within the
mitochondria on its heme group, and inhibition of cyto-
chrome c nitrosylation can diminish its capacity to acti-
vate caspases (Schonhoff et al., 2003). Furthermore,Figure 2. The Formation of the Mammalian
Apoptosome
Apaf-1 exists in the cytosol as an inactive
monomer prior to cytochrome c release
from the mitochondria. After release, cyto-
chrome c binds to Apaf-1, induces its confor-
mational change, and allows for dATP hydro-
lysis. Apaf-1 subsequently oligomerizes into
a heptameric structure; caspases and IAPs
are then recruited to the complex.
Review
551cytochrome c may be sensitive to the cellular redox
state, as treatment of cytochrome c with reducing
agents abolishes its ability to activate caspases
(Schonhoff et al., 2003; Suto et al., 2005).
Although the biochemistry of apoptosome formation
has been reconstituted by using purified components
in vitro, an understanding of the composition of the na-
tive apoptosome in apoptotic cells has emerged only re-
cently. The successful immunoprecipitation of catalyti-
cally active apoptosomes from Jurkat cells has
revealed that the native apoptosome (at least in this
cell type) contains caspase-3 and XIAP in addition to
Apaf-1 and caspase-9 (Hill et al., 2004). This study also
intimates that the interaction of XIAP with caspase-9 is
necessary for caspase-3 association with the apopto-
some. Interestingly, it has been suggested that Smac
or Omi/HtrA2, which are coordinately released from
the mitochondrial intermembrane space with cyto-
chrome c, may displace XIAP from the apoptosome
and thereby increase apoptosomal activity (Twiddy
et al., 2004). These findings raise the intriguing possibil-
ity that despite its ability to inhibit caspases, XIAP may
initially recruit caspase-3 to the apoptosome, with sub-
sequent displacement of XIAP by Smac or Omi leading
to full apoptosomal activation.
The precise role of the nucleotide dATP in apopto-
some formation has, until recently, been somewhat
mysterious. However, recent work by Xiaodong Wang
and colleagues demonstrates that dATP exists as a co-
factor with monomeric Apaf-1, is hydrolyzed to dADP
upon activation with cytochrome c, and is subsequently
exchanged for exogenous dATP to generate the active
apoptosome (Kim et al., 2005). Interestingly, if the con-
centration of cellular dATP is insufficient for nucleotide
exchange after hydrolysis, Apaf-1 will oligomerize into
an inactive apoptosome that lacks the capacity to acti-
vate caspase-9. In addition, the structure of a C-termi-
nally truncated (lacking the inhibitory WD-40 repeats
and hence constitutively active) Apaf-1 has been eluci-
dated and was found to be bound to hydrolyzed nucle-
otide, providing additional evidence that nucleotide hy-
drolysis is integral to the formation of a functional
apoptosome (Riedl et al., 2005).
Evolution of the Apoptosome
Caspase-activating apoptosomes are not unique to ver-
tebrates, though the ways in which apoptosomes are
regulated have undergone significant change over evo-
lutionary time. Although proteins distantly related to
caspases exist in single-celled eukaryotes, there is no
evidence for an apoptosome in unicellular organisms.
Some of the most intensively studied apoptosomes
are found in invertebrates. Indeed, the first character-
ized apoptosome components were identified in the
nematode Caenorhabditis elegans, an organism whose
highly tractable genetics have been used to advance
the study of apoptotic regulatory pathways (Metzstein
et al., 1998). A core pathway involving four proteins
(CED-3, CED-4, CED-9, and EGL-1) controls apoptosis
during C. elegans development. CED-3, the founding
member of the caspase family, is a zymogenic protease
activated by the adaptor protein CED-4, which bears
structural similarity to mammalian Apaf-1, though lacks
the autoinhibitory WD-40 repeats (Chinnaiyan et al.,
1997; Irmler et al., 1997; Seshagiri and Miller, 1997;Wu et al., 1997; Yang et al., 1998; Yuan and Horvitz,
1992). Rather, in the absence of an apoptotic stimulus,
CED-4 is sequestered from CED-3 through an interac-
tion with the protein CED-9, which is tethered to the mi-
tochondria (Chen et al., 2000; Chinnaiyan et al., 1997;
Hengartner and Horvitz, 1994; James et al., 1997; Spec-
tor et al., 1997; Wu et al., 1997). Although CED-9 has
sequence homology to antiapoptotic Bcl-2 family mem-
bers (and Bcl-2 can complement C. elegans CED-9
mutants), the paradigm of direct apoptosomal regula-
tion by Bcl-2 family members does not appear to extend
to vertebrates, where these proteins act upstream to
regulate mitochondrial cytochrome c release. In the
worm, cells fated to die induce apoptosis through the
transcriptional upregulation of EGL-1 (which shares
weak sequence homology with proapoptotic Bcl-2 fam-
ily members), whose role is to disrupt the interaction of
CED-9 and CED-4, thereby allowing CED-4 to activate
CED-3 (Conradt and Horvitz, 1998; del Peso et al.,
1998, 2000; Parrish et al., 2000). The C. elegans apopto-
some appears to be tetrameric, rather than heptameric,
as in vertebrate cells, and seems to lack detectable
ATPase or dATPase activity (Yan et al., 2005). Although
the mitochondria may be involved in regulating forma-
tion of the C. elegans apoptosome (by providing a site
for CED-9-mediated sequestration of CED-4), there is
no compelling evidence that release of proteins from
the mitochondria (e.g., cytochrome c) affects formation
of the C. elegans apoptosome. However, a recent study
has demonstrated that Drp-1, a component of the mito-
chondrial fission machinery, is involved in the promotion
of both mitochondrial fragmentation and caspase-
dependent cell death in C. elegans (Jagasia et al.,
2005). Moreover, CED-9 and EGL-1 act in opposition to
promote or inhibit mitochondrial fragmentation, respec-
tively. This is particularly provocative, as mammalian
Drp-1 has been implicated in both mitochondrial fission
and cytochrome c release in mammalian cells and the
proapoptotic Bcl-2 protein Bax can promote mitochon-
drial fission (Frank et al., 2001; Karbowski et al., 2002).
Genome sequencing has allowed for the identification
of apoptosomal components in a number of inverte-
brates besides the worm. Based on such sequence
analyses, the Drosophila melanogaster protein Dark/
Hac-1/Dapaf-1 was identified as a potential homolog
of mammalian Apaf-1 (Kanuka et al., 1999; Rodriguez
et al., 1999; Zhou et al., 1999; Zimmermann et al.,
2002). Like its worm and vertebrate counterparts, Dark
serves as an adaptor molecule to promote oligomeriza-
tion and activation of Dronc, a zymogenic caspase that
acts in a capacity similar to mammalian caspase-9
(Chew et al., 2004; Quinn et al., 2000). Dronc activation
promotes cleavage of DrICE, another pro-caspase that
is responsible, in part, for the subsequent execution of
the apoptotic program (Fraser et al., 1997). New struc-
tural evidence suggests that the D. melanogaster apop-
tosome exists as a ‘‘double apoptosome’’ with two octa-
meric rings lying face to face, and that formation of this
structure requires the nucleotide dATP (Yu et al., 2006).
Although Dark (like Apaf-1) has an N-terminal CARD,
a central domain with homology to CED-4, and a C-ter-
minal domain with multiple WD-40 repeats (the domain
responsible for the autoinhibition of Apaf-1), the ques-
tion of whether Dark requires any activating stimulus
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552Table 1. Physiological Regulation of the Apoptosome
Factor Regulating
the Apoptosome
Activation
or Inhibition Mechanism of Action References
Cytochrome c Activation Inducing Apaf-1 activation/oligomerization Liu et al., 1996; Zou et al., 1997
ERK Inhibition Phosphorylating caspase-9 Allan et al., 2003; Tashker et al., 2002
Akt Inhibit Phosphorylating caspase-9 Cardone et al., 1998
PKA Inhibition Preventing caspase-9 binding to Apaf-1 Martin et al., 2005
PKCzeta Inhibition Phosphorylating caspase-9 Brady et al., 2005
APIP Inhibition Preventing caspase-9 binding to Apaf-1 Cho et al., 2004
XIAP Inhibition Binding to active caspase-9 Srinivasula et al., 2001; Hill et al., 2004
Aven Inhibition Preventing Apaf-1 oligomerization Chau et al., 2000
Hsp70 Inhibition Binding to Apaf-1 and preventing caspase-9
binding
Beere et al., 2000; Saleh et al., 2000
Hsp90 Inhibition Binding to Apaf-1 and preventing Apaf-1
oligomerization
Pandey et al., 2000
Hsp27 Inhibition Binding to cytochrome c and preventing its
interaction with Apaf-1
Bruey et al., 2000
HBXIP Inhibition Binding to caspase-9 and preventing its
interaction with Apaf-1
Marusawa et al., 2003
TUCAN Inhibition Binding to caspase-9 and preventing its
interaction with Apaf-1
Pathan et al., 2001
Nucling Activation Binding to Apaf-1/caspase-9 complexes,
translocation to nucleus
Sakai et al., 2004
NAC Activation Binding to Apaf-1/promoting caspase
activation
Chu et al., 2001
PHAPI Activation Promoting caspase-9 association with the
apoptosome
Jiang et al., 2003
ProT Inhibition Preventing apoptosome formation Jiang et al., 2003
AFP Activation Promoting caspase recruitment to
apoptosome
Semenkova et al., 2003
AChE Activation Promoting interaction between cytochrome c
and Apaf-1
Park et al., 2004
Nitric oxide donors Inhibition Preventing Apaf-1 oligomerization Zech et al., 2003
Potassium ions Inhibition Preventing Apaf-1 oligomerization Cain et al., 2001
Diarylurea compounds Inhibition Preventing Apaf-1 oligomerization Lademann et al., 2003remains controversial. By analogy to Apaf-1, it was orig-
inally hypothesized that cytochrome c release from the
mitochondria might activate Dark. Consistent with this
notion were reports demonstrating coprecipitation of
Dark with cytochrome c and some capacity for exoge-
nous mammalian cytochrome c to alter Dark sedimenta-
tion in gradients (Dorstyn et al., 2002; Kanuka et al.,
1999; Rodriguez et al., 1999). Arguing against a role for
cytochrome c in Dark activation, however, other reports
have found no detectable cytochrome c release after de-
livery of an apoptotic stimulus in S2 cells (a D. mela-
nogaster cell line), and lysates prepared from these cells
are refractory to the addition of cytochrome c (Dorstyn
et al., 2004; Kanuka et al., 1999; Varkey et al., 1999; Zim-
mermann et al., 2002). Furthermore, the use of RNA
interference to knock down cytochrome c does not
appear to alter the progression of apoptosis in D. mela-
nogaster cell lines (Dorstyn et al., 2004; Zimmermann
et al., 2002). Additionally, cytochrome c is not required
for the formation of the D. melanogaster double apopto-
some, nor does it appear to interact with this complex
(Yu et al., 2006). Given these findings, recent studies
from Hermann Steller’s group that convincingly demon-
strate a role for cytochrome c in caspase activation as-
sociated with spermatid differentiation are difficult to
place within our current understanding of D. mela-
nogaster apoptosomal function (Arama et al., 2003,
2005). This pathway of spermatid differentiation seems
to be dependent upon Dark and Dronc, raising the in-
triguing possibility that the D. melanogaster apopto-some can be cytochrome c responsive in particular de-
velopmental contexts. Alternatively, cytochrome c may
have some target other than Dark or Dronc that can
act through this pathway. Furthermore, in that knock-
down or mutation of the D. melanogaster IAP, DIAP1,
is sufficient to induce apoptosis, it may not be necessary
to invoke a Dark activator in D. melanogaster apoptosis
(Goyal et al., 2000; Lisi et al., 2000; Yoo et al., 2002; Zim-
mermann et al., 2002). Indeed, under most, if not all, cir-
cumstances, Dark may well have the capacity for consti-
tutive activity in the absence of DIAP1, such that
activation of the D. melanogaster apoptosome would
simply involve the removal or inactivation of DIAP1.
Physiological Regulation of the Apoptosome
With an increased understanding of apoptosome forma-
tion and function has come the recognition that the
apoptosome can serve as a distinct locus of apoptotic
regulation. Many factors have been discovered that con-
trol the efficacy of apoptosome formation and activation
under normal physiological conditions (summarized in
Table 1). In particular, kinase signaling has been shown
in a number of settings to affect the activity and forma-
tion of the apoptosome, oftentimes through the direct
phosphorylation of apoptosomal constituents. The first
report of such apoptosomal regulation by phosphoryla-
tion came from studies showing that the prosurvival
kinase Akt could phosphorylate human caspase-9 on
serine 196 and thereby prevent Apaf-1/cytochrome c
activation of caspase-9 (Cardone et al., 1998). The
Review
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question, however, as the Akt phosphorylation site on
caspase-9 was found to be absent even in other mam-
mals (i.e., dog and mouse); hence, the broad signifi-
cance of Akt-mediated caspase-9 phosphorylation is
still not clear (Rodriguez et al., 2000). Subsequent to
these studies, a number of other antiapoptotic kinases
have been shown to inhibit caspase-9 by direct phos-
phorylation. ERK, a member of the MAPK family, inhibits
cytochrome c-induced apoptosome activation in cell-
free extracts prepared from both Xenopus laevis eggs
and mammalian tissue culture cells (Allan et al., 2003;
Tashker et al., 2002). This inhibition appears to result
from the direct phosphorylation of caspase-9 by ERK
at threonine 125 in mammals (Allan et al., 2003). Addi-
tionally, protein kinase A (PKA) signaling has been
shown to alter formation of the apoptosome by prevent-
ing the recruitment of caspase-9 to Apaf-1 (Martin et al.,
2005). Although three sites of PKA-mediated caspase-9
phosphorylation have been mapped, mutation of these
sites indicates that (in the models tested) they are irrele-
vant to the prevention of Apaf-1/caspase-9 interactions,
suggesting that another PKA substrate is important for
apoptosome inhibition. Protein kinase C zeta (PKCzeta),
an atypical isoform of PKC that is activated by hyperos-
motic stress, has also been demonstrated to phosphor-
ylate caspase-9 (Brady et al., 2005). This phosphoryla-
tion occurs at serine 144 in humans and appears to
directly inhibit Apaf-1-mediated activation of caspase-9.
In addition to the posttranslational modification of
apoptosomal components, there are a variety of pro-
teins that affect the activity of the apoptosome via direct
interactions. As described above, XIAP is a direct cas-
pase inhibitor that can bind to and inhibit apoptosomal
caspase-9, as well as its downstream target, caspase-
3. More specifically, XIAP has been found as a constitu-
ent of native apoptosomes, and it can inhibit caspase
activation through an interaction with cleaved cas-
pase-9 (Hill et al., 2004; Srinivasula et al., 2001). The
cleavage of caspase-9 bound to Apaf-1 exposes an
IAP interaction motif (ATPF in human caspase-9) related
to sequences present in other endogenous XIAP binding
proteins (i.e., AVPI in Smac).
Additional proteins reported to bind to the apopto-
some and inhibit its activity include Aven, Hsp90,
Hsp27, Hsp70, HBXIP, TUCAN, and APIP. Although
Aven was originally identified in a yeast two-hybrid
screen for Bcl-XL interactors (Chau et al., 2000), it was
also found to bind to Apaf-1 and prevent its oligomeriza-
tion, thus impairing its ability to interact with caspase-9.
Hsp70 binding to Apaf-1 prevents the interaction of cas-
pase-9 with Apaf-1, although whether it accomplishes
this by affecting Apaf-1 oligomerization is debated
(Beere et al., 2000; Saleh et al., 2000). Additionally,
both Hsp90 and APIP have been demonstrated to inter-
act with Apaf-1 and inhibit the interaction between
Apaf-1 and caspase-9 (Cho et al., 2004; Pandey et al.,
2000). Interestingly, Hsp27 appears to inhibit the apop-
tosome through a unique mechanism that involves
binding to cytosolic cytochrome c, preventing its inter-
action with Apaf-1, and subsequently inhibiting the acti-
vation of caspase-9 (Bruey et al., 2000). Another factor,
HBXIP, reportedly complexes survivin (an IAP relative) to
bind to caspase-9 and inhibit its interaction with Apaf-1(although neither protein binds to caspase-9 individu-
ally) (Marusawa et al., 2003). TUCAN is a recently identi-
fied CARD-containing protein that can complex with
caspase-9 and prevent cytochrome c-induced caspase
activation (Pathan et al., 2001). In addition to these
apoptosome inhibitors, a recently identified protein
termed Nucling has been shown to stably interact with
Apaf-1/caspase-9 complexes after cellular stress to
promote the translocation of Nucling/Apaf-1/caspase-
9 complexes into the nucleus; this relocalization report-
edly enhances apoptosome-mediated caspase-9 acti-
vation (Sakai et al., 2004). The protein NAC can also
interact with Apaf-1 through a CARD-CARD interaction
and can promote the activation of caspases on the
apoptosome (Chu et al., 2001).
Various factors have been found to modulate apopto-
somal activity without an apparent direct physical con-
tact with or modification of apoptosomal constituents.
The proteins PHAPI and ProT were identified as apopto-
somal regulators during a study examining activation of
the apoptosome by small molecules (Jiang et al., 2003).
PHAPI (putative HLA-DR-associated protein-1) pro-
motes caspase-9 association with the apoptosome after
Apaf-1 oligomerization. In contrast, ProT (prothymosin-
a) inhibits the successful formation of the apoptosome
and subsequent caspase activation. Moreover, the
RNA binding protein HuR can enhance the antiapoptotic
effects of ProT by binding to ProT RNA and enhancing
its translation (Lal et al., 2005). Neither PHAPI nor ProT
appears to exert its effects through direct interaction
with the apoptosome. Other proteins that indirectly reg-
ulate the apoptosome include a-fetoprotein (AFP),
which promotes caspase activation by recruiting cas-
pases to the complex (Semenkova et al., 2003), and ace-
tylcholinesterase (AChE), which appears to promote the
interaction between cytochrome c and Apaf-1 (Park
et al., 2004). Furthermore, nitric oxide donors (which
modulate cytochrome c activity through nitrosylation
as described above) can act directly at the apoptosome
to prevent the oligomerization of Apaf-1 and the CARD-
CARD interaction between caspase-9 and Apaf-1 (Zech
et al., 2003). Recent efforts aimed at finding small-mole-
cule inhibitors of apoptosis identified diarylurea com-
pounds as inhibitors of Apaf-1 oligomerization and
apoptosome formation (Lademann et al., 2003). Finally,
the intracellular concentration of potassium (K+) may
dictate apoptosome activity, as high K+ concentrations
prevent the oligomerization of Apaf-1 and subsequent
incorporation of caspase-9 into the apoptosome, thus
inhibiting caspase activation and apoptosis (Cain
et al., 2001).
Importance of the Apoptosome and Its Regulation
during Development
Apoptosomal components play significant roles in nor-
mal developmental processes. Apaf-1 null mice display
prominent craniofacial and brain abnormalities and ex-
hibit conspicuous lethality by embryonic day 16.5 (Cec-
coni et al., 1998; Yoshida et al., 1998). In addition,
embryonic stem cells, thymocytes, and fibroblasts de-
rived from these animals are extraordinarily resistant
to mitochondria-mediated apoptotic cell death despite
the normal release of cytochrome c. Caspase-9 null
mice display similar deformities, as they die perinatally
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normal developmental apoptosis (Hakem et al., 1998;
Kuida et al., 1998). In addition, embryonic stem cells,
thymocytes, and embryonic fibroblasts derived from
these animals are refractory to apoptotic signals that
successfully induce mitochondrial cytochrome c re-
lease. Interestingly, Dark hypomorphic flies bearing
loss-of-function mutations at the Dark locus exhibit hy-
perplasia of the central nervous system resulting from
reduced developmental programmed cell death, which
is highly reminiscent of the phenotypes observed in
Apaf-1 null mice (Rodriguez et al., 1999). Similarly, flies
with mutations in the Dark-activated caspase Dronc ex-
hibit supernumerary neurons, and Dark and Dronc mu-
tant flies do exhibit a number of other developmental de-
fects (some overlapping) that may be attributable to
defects in programmed cell death (Chew et al., 2004;
Daish et al., 2004; Xu et al., 2005).
To further analyze apoptosome function during mu-
rine development, mice devoid of cytochrome c have
been generated, and these mice die perinatally by em-
bryonic day 8.5 due to developmental defects (Li et al.,
2000). Cells derived from these mice do show defects
in apoptosis, but they also show a significant impair-
ment in cellular respiration, which precluded a complete
analysis of cytochrome c function in apoptosis during
development. To circumvent this problem, knockin
mice were engineered to express a mutant cytochrome
c allele with a point mutation rendering it unable to acti-
vate Apaf-1, but competent for cellular respiration (Hao
et al., 2005). These mice also die perinatally with central
nervous system defects in a similar time frame to Apaf-1
null and caspase-9 null mice. Fibroblasts derived from
these mice are remarkably refractory to apoptosis be-
cause they are unable to form active apoptosomes. In-
terestingly, a previously identified mutation leading to
defects in neural tube closure was found to reside in
the Apaf-1 gene, resulting in reduced Apaf-1 mRNA
and protein and a concomitant decrease in apoptosis
(Honarpour et al., 2001).
The striking brain phenotypes seen in mice bearing
knockouts of apoptosomal components highlight the
particular importance of the apoptosome in neuronal de-
velopmental apoptosis. Despite this requirement for the
apoptosome in the establishment of brain architecture
during development, neurons undergo a remarkable
shift in apoptosome function over the course of develop-
ment. It was initially found that sympathetic neurons are
not readily susceptible to death induced by the introduc-
tion of cytochrome c into the cytoplasm (Deshmukh and
Johnson, 1998; Neame et al., 1998). Rather, in response
to a particular apoptotic stimulus (e.g., NGF withdrawal),
they must acquire ‘‘competence-to-die’’ after cyto-
chrome c release. These observations suggested that
at least one major regulatory event (besides cytochrome
c release) is required for the apoptosis of these cells.
This resistance to cytochrome c-induced apoptosis in
postmitotic neurons is thought to reflect the need to
maintain these cells over the lifetime of the organism.
In sympathetic neurons, competence-to-die can be
induced by the introduction of exogenous Smac into
the cytosol, suggesting that counteracting the effects
of IAPs is critically important in the death of these neu-
rons (Deshmukh et al., 2002). Indeed, subsequent workhas demonstrated that sympathetic neurons from
XIAP-deficient mice die very efficiently in response to
cytochrome c without additional proapoptotic stimuli
(Potts et al., 2003). A model for understanding this cyto-
chrome c resistance in postmitotic neurons has been
established by using PC12 cells, a naive cell line that
can be differentiated into mature neurons. These studies
have confirmed that postmitotic, neuronally differenti-
ated PC12 cells are remarkably refractory to cyto-
chrome c-induced apoptosis (much like sympathetic
neurons drawn directly from the mice) when compared
to naive mitotic cells (Vyas et al., 2004; Wright et al.,
2004). This difference in sensitivity to cytochrome c
can be attributed to downregulation of Apaf-1 during
the process of differentiation, and the resulting loss of
apoptosome activity has been postulated to underlie
the increased susceptibility of these cells to apoptotic
regulation by IAP proteins (Figure 3). Indeed, it has
been demonstrated that Apaf-1 expression decreases
during brain maturation in the rat, further validating the
above-mentioned findings (Yakovlev et al., 2001). Inter-
estingly, more recent studies have demonstrated that
another postmitotic cell, the mature cardiomyocyte, is
also refractory to cytochrome c-induced apoptosome
activation (Potts et al., 2005; Sanchis et al., 2003).
Outside of the nervous system, analyses of Apaf-1
function have revealed an assortment of developmental
roles for the apoptosome. Disruption of the Apaf-1 gene
leads to a significant decrease in cell death in the inner
ear epithelium and consequent severe morphogenetic
defects of the inner ear (Cecconi et al., 2004). In addition,
there is evidence to suggest that appropriate spatiotem-
poral downregulation of the apoptosome can be critical
for developmental events. For example, loss of murine
HAND2, a transcription factor required for cardiac, pha-
ryngeal arch, and limb development, leads to embryonic
cell death from heart failure that is rescued by loss of
Apaf-1 (Aiyer et al., 2005). These data suggest that
HAND2 must oppose the action of Apaf-1 during devel-
opment, and they imply that the apoptosome must be
kept in check at particular times and places for proper
development to proceed.
Pathological Regulation of the Apoptosome
Apoptosomal Regulation in Cancer
The inhibition of apoptosis has been characterized as
a critical hallmark of cancer (Hanahan and Weinberg,
2000). Thus, it is perhaps not surprising that alterations
in apoptosome function have been documented in
a number of tumor types (summarized in Table 2). Mod-
ulation of apoptosome function in cancer was first ob-
served in metastatic melanomas in which Apaf-1 protein
was lost due to methylation-induced transcriptional si-
lencing (Soengas et al., 2001). Other groups have further
characterized and verified apoptosomal inactivation in
both melanoma cell lines and tissue samples (Baldi
et al., 2004; Dai et al., 2004; Fujimoto et al., 2004a,
2004b; Zanon et al., 2004). As most currently used che-
motherapeutic agents kill malignant cells by promoting
mitochondrial cytochrome c release, such loss of apop-
tosome activity likely contributes significantly to chemo-
resistance in melanomas.
The loss of apoptosome function in tumors does not
necessarily reflect alterations in the core apoptosomal
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555Figure 3. Decreased Apoptosome Activation
in Neuronally Differentiated PC12 Cells
Naive PC12 cells display robust caspase ac-
tivation in response to cytosolic cytochrome
c. However, after neuronal differentiation,
PC12 cells display reduced responsiveness
to cytochrome c as Apaf-1 is downregulated,
allowing XIAP to function as a more effective
inhibitor of caspases.component Apaf-1. In the non-small cell lung carcinoma
(NSCLC) cell line NCI-H460, dysfunctional apoptosome
activity has been attributed to the overexpression of
XIAP (Yang et al., 2003). Accordingly, an XIAP-targeting
Smac peptide was able to restore the sensitivity of these
cells to cytochrome c-induced apoptosis and act in con-
cert with chemotherapeutic agents (e.g., cisplatin and
taxol) to reduce the tumor growth of NCI-H460 xeno-
grafts. Other studies of NSCLC have also revealed de-
fects in apoptosome activation in cell lines and tumor
tissues despite evidence that various apoptosomal pro-
teins may in fact be upregulated (Krepela et al., 2004,
2006).
Posttranslational modification of apoptosomal com-
ponents may also contribute to cytochrome c resistance
in malignancies. For example, Bcr-Abl, a constitutively
active tyrosine kinase responsible for the pathogenesisof chronic myelogenous leukemia (CML), prevents cyto-
chrome c-induced apoptosome activation by prevent-
ing the interaction of pro-caspase-9 with Apaf-1 (De-
ming et al., 2004). Preliminary evidence suggests that
this impairment in apoptosome formation may be due
to phosphorylation of Apaf-1 induced by downstream
Bcr-Abl signaling (i.e., not by direct phosphorylation
by Bcr-Abl). Defects in apoptosome activation have
been demonstrated in other leukemic cell types, but in
these cases, cytochrome c resistance stems from a defi-
ciency in Apaf-1 protein (possibly due to methylation of
the promoter, as in malignant melanomas) (Fu et al.,
2003; Furukawa et al., 2005; Jia et al., 2001, 2003).
Other examples of tumors reported to be defective in
either apoptosome formation or function include blad-
der cancers, in which Apaf-1 is downregulated, and glio-
blastomas, in which LOH-induced Apaf-1 inactivationTable 2. Apoptosomal Regulation in Cancer
Tumor Type
Activation
or Inhibition Mechanism of Action References
Melanoma Inhibition Loss of Apaf-1-promoter methylation Soengas et al., 2001
NSCLC Inhibition XIAP overexpression Yang et al., 2003
CML Inhibition Bcr-Abl-mediated inhibition of caspase-9/Apaf-1
binding
Deming et al., 2004
Other leukemias Inhibition Loss of Apaf-1-promoter methylation Jia et al., 2001, 2003
Bladder cancer Inhibition Loss of Apaf-1 Jia et al., 2001
Cervical cancer Inhibition Loss of Apaf-1 Leo et al., 2005
Glioblastoma Inhibition Loss of Apaf-1-LOH Watanabe et al., 2003
Fibrosarcoma Inhibition Loss of Apaf-1 and caspase-9 due to AMF
signaling
Haga et al., 2003
Ovarian cancer Inhibition Inhibition of caspase-9/Apaf-1 binding Liu et al., 2002; Wolf et al., 2001
Non-clear cell renal carcinoma Inhibition Unknown Gerhard et al., 2003
Breast cancer Activation PHAPI-mediated enhancement of caspase-9/Apaf-1
binding
Schafer et al., 2006
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556Figure 4. PHAPI-Mediated Sensitivity to Cy-
tochrome c-Induced Apoptosis in Breast
Cancer
Malignant mammary epithelial cells activate
caspases more efficiently and robustly after
the release of cytochrome c into the cytosol.
This is due to the overexpression of PHAPI,
which causes enhanced recruitment of cas-
pase-9 to the apoptosome.has been observed (Jia et al., 2001; Watanabe et al.,
2003). The loss of Apaf-1 also correlated with aggressive
tumor behavior in cervical cancer (Leo et al., 2005), and
in fibrosarcoma cells, both Apaf-1 and caspase-9 are
downregulated in a mechanism dependent on the sig-
naling of AMF (autocrine motility factor), a molecule im-
plicated in tumor malignancy (Haga et al., 2003). Further-
more, despite abundant Apaf-1 expression, ovarian
cancer cell lines and tumors have been characterized
as having defective apoptosome function, potentially
arising from a lack of caspase-9 bound to oligmomer-
ized Apaf-1 (Liu et al., 2002; Wolf et al., 2001). Lastly, not-
withstanding normal apoptosome function in clear cell
RCC (renal cell carcinoma), non-clear cell RCC samples
have defects in their responsiveness to cytosolic cyto-
chrome c due to a yet to be determined mechanism
(Gerhard et al., 2003).
Recently, a unique mechanism of apoptosomal regu-
lation has been uncovered in one of the most prevalently
studied cancers, breast cancer (Figure 4). By assaying
the cytochrome c sensitivity of a panel of breast cancer
cell lines, it was found that breast cancer cells are actu-
ally exquisitely sensitive to cytochrome c-induced apo-
ptosis when compared to normal mammary epithelial
cells (Schafer et al., 2006). While the malignant mam-
mary epithelial cells displayed evidence of hyperactive
apoptosomes, they apparently maintained the require-
ment of tumor cells for apoptotic inhibition, as they
were resistant to chemotherapy-induced cytochrome c
release. This unique sensitivity to cytosolic cytochrome
c in breast cancer cells appears to be dictated by over-
expression of the apoptosomal regulator PHAPI, which
was observed in both breast cancer cells and mammary
tumors (Schafer et al., 2006). These findings raise the
intriguing possibility that malignant mammary epithelialcells could be killed with reasonable selectivity by the in-
troduction of cytosolic cytochrome c or a chemothera-
peutic agent that mimics its action. Indeed, it has been
suggested in other studies that stimulating the apopto-
some might serve as a means to selectively kill cancer
cells (Mashima et al., 2005; Nguyen and Wells, 2003).
That said, downregulation of caspase-3 is observed in
some breast cancer cells, so cytochrome c-mimetic
therapies would have to be restricted to caspase-3-pos-
itive breast cancers (Devarajan et al., 2002).
Apoptosomal Regulation in Other Pathological
Conditions
Aberrant apoptosome function contributes not only to
carcinogenesis, but it has also been implicated in the in-
appropriate apoptosis characteristic of various degen-
erative disorders. For example, neural precursor cells
(NPCs) lacking Apaf-1 are resistant to a variety of neuro-
degenerative apoptotic inducers (Cozzolino et al., 2004).
Although proapoptotic stimuli (e.g., amyloid b-peptide)
could stimulate cytochrome c release in these cells,
the released cytochrome c was degraded by the protea-
some when Apaf-1 was absent. Additionally, by using
a D. melanogaster model, polyglutamine-induced cell
death (characteristic of Huntington’s disease) was
found to be dramatically suppressed in the absence of
the D. melanogaster Apaf-1 homolog, Dark, further sug-
gesting a role for the apoptosome in the pathogenesis of
neurodegenerative disorders (Sang et al., 2005). If apop-
tosome activity is necessary for the cell death character-
istic of neurodegeneration, then inactivation of the
apoptosome might provide a therapeutic avenue for
treating these disorders. One recently identified Apaf-1-
interacting inhibitor, AIP (a splice variant of caspase-9
that is expressed endogenously in the brain), was found
to be capable of protecting neurons from cell death
Review
557induced by cerebral ischemia (Cao et al., 2004). Accord-
ingly, AIP overproduction has been proposed as a neu-
roprotective strategy to prevent neurodegeneration as
well as stroke-induced neuronal injury.
Inappropriate apoptosome activity has also been
shown to play a role in heart disease and in ischemic re-
nal failure. It has long been known that cardiac myocytes
are lost to apoptosis during the aging process, contrib-
uting to the development of various cardiac disorders.
Recently, cytosolic cytochrome c content was found
to be elevated in the hearts of 16- and 24-month-old
mice when compared to 6-month-old mice, suggesting
that changes in cytochrome c-induced apoptosome ac-
tivation may promote age-related loss of cardiac myo-
cytes (Phaneuf and Leeuwenburgh, 2002). Of potential
therapeutic interest, the amino acid taurine has been
shown to limit the apoptosis of cardiomyocytes during
myocardial infarction (Takatani et al., 2004). This protec-
tive effect of taurine stems from its ability to prevent the
proper formation of the apoptosome by preventing the
interaction between caspase-9 and Apaf-1. In the case
of kidney disease, the apoptosis of tubular cells has
been implicated in the progression of ischemic renal fail-
ure. However, a shift to an acidic pH can inhibit the in-
duction of ATP depletion-induced apoptosis in tubular
cells by preventing the association of caspase-9 and
Apaf-1 (Brooks et al., 2005). Thus, lowering cellular pH
might be an effective means by which to reduce tubular
cell apoptosis and the subsequent development of
ischemia-induced renal failure.
Conclusions, Perspectives, and Future Directions
Despite recent progress in understanding the role of the
apoptosome during development, adult tissue homeo-
stasis, and pathogenesis, a number of questions remain
concerning its precise mechanism of activation/forma-
tion. For example, we do not yet know the precise bind-
ing site of cytochrome c on Apaf-1, nor do we know how
dADP is exchanged for dATP after the initial hydrolysis
of dATP. The studies of the cytochrome c knockin
mice described above have yielded some data that chal-
lenge our current understanding of apoptosome func-
tion (Hao et al., 2005). In contrast to fibroblasts, thymo-
cytes from these animals retain sensitivity to apoptotic
stimuli despite the inactivation of cytochrome c. After
g-irradiation, caspase activation occurs in the absence
of detectable Apaf-1 oligomerization, but in an Apaf-1-
dependent manner. This suggests the presence (at least
in certain cell types) of a cytochrome c-independent,
Apaf-1-dependent mechanism of caspase-9 activation.
These findings suggest the possible existence of alter-
native mechanisms to nucleate an Apaf-1/caspase-9
apoptosome that might bypass a requirement for mito-
chondria. The existence of mechanisms to inhibit cas-
pase activation at the level of the apoptosome raises
the question of whether cells that have been induced
to undergo cytochrome c release can survive in the
long term after permeablization of their mitochondria.
There are conflicting results concerning clonogenic sur-
vival after loss of mitochondrial cytochrome c (Ekert
et al., 2004; Ricci et al., 2003, 2004; Waterhouse et al.,
2001). It may be true that cells differ in their ability to
withstand transient mitochondrial permeablization. In
postmitotic neurons, for example, restoration of nervegrowth factor after growth factor deprivation allows for
long-term survival despite cytochrome c release (Desh-
mukh et al., 2000). While this must depend, in part, on
the remarkable resistance of mature neurons to cyto-
solic cytochrome c, it also suggests that mitochondria
in these cells can ‘‘recover’’ after permeablization. It
has been suggested that import of newly synthesized
cytochrome c could restore respiratory chain function
after mitochondrial repair. Additionally, even nonneuro-
nal cells (which do not necessarily have any resistance
to cytosolic cytochrome c) have been reported to main-
tain mitochondrial respiratory function after the perme-
ablization of the mitochondria by utilizing cytosolic cyto-
chrome c (Waterhouse et al., 2001).
Emerging evidence that the apoptosome may be al-
tered in various pathological conditions raises the excit-
ing possibility that apoptosome modulators may act as
therapeutics. Just as the relative sensitivity of malignant
mammary epithelial cells to cytochrome c suggests that
cytochrome c mimetics might be effective in breast can-
cer therapy (Schafer et al., 2006), the remarkable resis-
tance of postmitotic neurons to cytochrome c raises
the possibility that brain tumor cells might be suscepti-
ble to similar therapeutic agents (Deshmukh and John-
son, 1998). The selective induction of apoptosis in tumor
cells has been a long-term goal of cancer researchers.
The continued study of apoptosomal formation, func-
tion, and regulation may soon make the apoptosome
a viable therapeutic target not only for cancer treatment,
but also for degenerative and developmental disorders.
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